Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro
Keywords: Chronic lymphocytic leukemia (CLL); Poly(ADP-ribose) polymerase (PARP); CEP-8983; Bendamustine